Development Flowchart
Partnerships with collaborating companies
- We design and produce the targeted subunits, evaluate their physical properties and immune characteristics, and conduct neutralization experiments.
- We work with potential partner companies to develop subunit vaccines, apply them to the development of mRNA/DNA vaccines, and develop testing technologies using monoclonal antibodies.